米RNA-145-5p在癌症中的作用 (综述)
1Department of Traditional Chinese Medicine, Guangxi Zhuang Autonomous Region People's Hospital, Nanning, Guangxi 530016, P.R. China.
Oncology reports
|January 31, 2025
概括
微RNA-145-5p在癌症中起着双重作用,作为瘤抑制剂或瘤基因. 本综述探讨了其作为诊断和预后生物标志物的潜力及其对癌症治疗的影响.
科学领域:
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
- 在瘤学瘤学.
背景情况:
- 微RNA-145-5p (miRNA-145-5p) 是一种参与细胞调节的非编码RNA.
- 它在恶性瘤中的功能可以是瘤抑制或瘤致癌,影响癌症的进展.
- 在癌症中miRNA-145-5p的完整作用需要进一步阐明.
研究的目的:
- 为提供miRNA-145-5p在癌症中的作用的全面概述.
- 研究其作为癌症诊断,预后和治疗反应的生物标志物的潜力.
- 评估其对化疗和放射治疗疗效的影响.
主要方法:
- 在癌症中对miRNA-145-5p的现有研究进行文献综述和综合.
- 对研究miRNA-145-5p的点和调控机制的研究进行分析.
- 关于miRNA-145-5p的临床应用和输送策略的当前发现的摘要.
主要成果:
- miRNA-145-5p在各种癌症中表现出上下文依赖的作用,同时作为瘤抑制剂和瘤基因.
- 它通过准下游基因和与上游调节器相互作用来影响瘤的进展.
- 新出现的证据表明,它有可能成为早期检测和预测治疗结果的生物标志物.
结论:
- miRNA-145-5p是癌症发展和进展的一个重要因素.
- 它的多面性作用凸显了其作为多功能生物标志物和治疗点的潜力.
- 对其传递机制的进一步研究对于有效的癌症治疗至关重要.
相关概念视频
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
02:39lncRNA - Long Non-coding RNAs
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...